ArticleCancers2026

Enzalutamide Plus ADT for the Treatment of mHSPC: Real-World Evidence from a Bulgarian Cohort.

Manoela Manova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.